Elizabeth K. M. Johnstone

Author

Harry Perkins Institute of Medical Research ORCID

Also Known As

E. K. Johnstone, Elizabeth Johnstone, Elizabeth K M Johnstone, Elizabeth K. M. Johnstone, Elizabeth K.M. Johnstone, Elizabeth KM Johnstone

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Harry Perkins Institute of Medical Research The University of Western Australia Queen Elizabeth II Medical Centre Australian Research Council Monash University

About

Elizabeth K. M. Johnstone is an author at Harry Perkins Institute of Medical Research specializing in medicine, gene expression, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	147
2	Natural Sciences	2	2	277
3	Engineering	1	1	43
4	Biochemistry	1	1	255
5	Biomolecular Engineering	1	1	43

Elizabeth K. M. Johnstone

Publications

810

Citations

H-Index

Page 1

	Year	Citations
Application of BRET to monitor ligand binding to GPCRs Leigh A. Stoddart, Elizabeth K. M. Johnstone, Amanda J. Wheal, Nature Methods Molecular RecognitionBiochemistryNatural SciencesNon-peptide LigandChemical Biology	2015	255
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer Ciara Duffy, Anabel Sorolla, Edina Wang, npj Precision Oncology	2020	157
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis R. J. Pickering, Christos Tikellis, Carlos J. Rosado, Journal of Clinical Investigation ImmunologyRenal InflammationInflammationMolecular PharmacologyTranscriptional Regulation	2018	82
Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time Carl W. White, Hannah Vanyai, Heng B. See, Scientific Reports	2017	60
Functional Interaction between Angiotensin II Receptor Type 1 and Chemokine (C-C Motif) Receptor 2 with Implications for Chronic Kidney Disease Mohammed Akli Ayoub, Yuan Zhang, Robyn S. Kelly, PLoS ONE	2015	51
AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis Bryna S.M. Chow, Martina Kočan, Matthew Shen, Journal of the American Society of Nephrology	2019	49
NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing Carl W. White, Elizabeth K. M. Johnstone, Heng B. See, Cellular Signalling Nanobret Ligand BindingEngineeringMolecular BiologyGenetic EngineeringGene Editing	2018	43
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer Emily Golden, Eleanor Woodward, Agustin Sgro, Nature Communications	2021	39
BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes Shannon O’Brien, Elizabeth K. M. Johnstone, Dominic Devost, Biochemical Pharmacology Signal TransductionSignaling PathwayCell RegulationBret-based AssayMedicine	2018	22
Receptor-Heteromer Investigation Technology and its application using BRET Elizabeth K. M. Johnstone, Kevin D. G. Pfleger Frontiers in Endocrinology	2012	20

Page 1